文献速递造血干细胞移植与细胞治疗

嵌合抗原受体T细胞治疗后移植物抗宿主病风险:T细胞的双向对立

Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells.
PubMed 文献 · Br J Haematol · 2021-05-25

本文综述了CAR-T细胞治疗中移植物抗宿主病(GVHD)的风险,涵盖异基因造血干细胞移植(HCT)后使用受者或供者来源CAR-T细胞,以及非HCT背景下使用自体或异基因T细胞疗法。文章强调需全面理解这些疗法的生物学与潜在毒性,以确保临床安全开发与应用。

要点

  • HCT后使用CAR-T细胞需警惕GVHD风险。
  • 异基因CAR-T细胞治疗同样存在GVHD风险。
  • 深入理解GVHD风险有助于安全推进CAR-T疗法。

核心结论

  • CAR-T细胞治疗中GVHD风险需在HCT后及非HCT多种场景下被充分认识,以保障安全开发与临床应用。

研究设计与样本

  • 本文为综述,讨论HCT后使用受者或供者来源CAR-T细胞及非HCT使用自体或异基因T细胞疗法时GVHD风险。

主要发现

  • HCT后使用CAR-T细胞及异基因CAR-T细胞治疗均可能引发GVHD,需引起重视。

临床怎么用

  • 临床使用CAR-T细胞时,应结合HCT史及细胞来源评估GVHD风险,并加强监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chimeric antigen receptor (CAR) T-cell therapy has brought a paradigm shift in the management of haematological malignancies and has opened novel avenues of investigational therapeutic strategies. Given these encouraging responses, it has become imperative to understand the full spectrum of biology and potential toxicities that can arise from these novel agents, as well as those under investigation. With the increasing use of CAR T-cell therapy for relapse following allogeneic haematopoietic cell transplantation (HCT) and the imminence of allogeneic CAR T cells, risks from T cell-based therapy, such as the previously well-recognised graft-versus-host disease (GVHD), have gained prominence and warrant explanation. In the present review, we discuss the risk of GVHD in the: (1) post-HCT setting using recipient or donor-derived CAR T cells, as well as (2) non-HCT setting using autologous, as well as allogeneic T-cell therapies. A better understanding of this risk is important to advance the field and ensure safe development and use of these agents in the clinic.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Sanber K, Savani B, Jain T, et al. Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. Br J Haematol. 2021. PMID: 34036558. doi:10.1111/bjh.17544

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。